Detalhe da pesquisa
1.
An artificial intelligence-powered PD-L1 combined positive score (CPS) analyser in urothelial carcinoma alleviating interobserver and intersite variability.
Histopathology
; 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38477366
2.
Discontinuation risk from adverse events: immunotherapy alone vs. combined with chemotherapy: a systematic review and network meta-analysis.
BMC Cancer
; 24(1): 152, 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291376
3.
Artificial Intelligence-Powered Hematoxylin and Eosin Analyzer Reveals Distinct Immunologic and Mutational Profiles among Immune Phenotypes in Non-Small-Cell Lung Cancer.
Am J Pathol
; 192(4): 701-711, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35339231
4.
Comprehensive Molecular Characterization of Adenocarcinoma of the Gastroesophageal Junction Between Esophageal and Gastric Adenocarcinomas.
Ann Surg
; 275(4): 706-717, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33086305
5.
Pan-cancer methylation analysis reveals an inverse correlation of tumor immunogenicity with methylation aberrancy.
Cancer Immunol Immunother
; 70(6): 1605-1617, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33230567
6.
Discovery of acquired molecular signature on immune checkpoint inhibitors in paired tumor tissues.
Cancer Immunol Immunother
; 70(6): 1755-1769, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33389015
7.
A phase I study of IMC-001, a PD-L1 blocker, in patients with metastatic or locally advanced solid tumors.
Invest New Drugs
; 39(6): 1624-1632, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34268711
8.
Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint Inhibitors.
Clin Infect Dis
; 71(2): 422-425, 2020 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31680143
9.
Interleukin 1 Up-regulates MicroRNA 135b to Promote Inflammation-Associated Gastric Carcinogenesis in Mice.
Gastroenterology
; 156(4): 1140-1155.e4, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30508510
10.
Severe late dysphagia after multimodal treatment of stage III/IV laryngeal and hypopharyngeal cancer.
Jpn J Clin Oncol
; 50(2): 185-192, 2020 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31711185
11.
Association between the exposure to anti-angiogenic agents and tumour immune microenvironment in advanced gastrointestinal stromal tumours.
Br J Cancer
; 121(10): 819-826, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31607749
12.
Clinical observation of lymphopenia in patients with newly diagnosed glioblastoma.
J Neurooncol
; 143(2): 321-328, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30982199
13.
BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression.
Int J Mol Sci
; 19(10)2018 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30326563
14.
Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer.
Gastric Cancer
; 20(1): 164-174, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26681196
15.
Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer.
Gastric Cancer
; 20(2): 254-262, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27147244
16.
Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: a retrospective study.
BMC Cancer
; 16: 116, 2016 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26884055
17.
Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications.
Gastric Cancer
; 19(2): 421-430, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26002144
18.
Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer.
Gastric Cancer
; 19(2): 597-606, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25749718
19.
Clinical Validation of Artificial Intelligence-Powered PD-L1 Tumor Proportion Score Interpretation for Immune Checkpoint Inhibitor Response Prediction in Non-Small Cell Lung Cancer.
JCO Precis Oncol
; 8: e2300556, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38723233
20.
Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04).
J Clin Oncol
; 42(11): 1241-1251, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37861993